• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆假尿嘧啶核苷水平反映血液透析患儿的体型。

Plasma pseudouridine levels reflect body size in children on hemodialysis.

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Departments of Medicine, VA Palo Alto HCS and Stanford University, 3801 Miranda Ave, Palo Alto, CA, 94304, USA.

出版信息

Pediatr Nephrol. 2020 Feb;35(2):305-312. doi: 10.1007/s00467-019-04369-6. Epub 2019 Nov 14.

DOI:10.1007/s00467-019-04369-6
PMID:31728748
Abstract

BACKGROUND

Dialysis in children as well as adults is prescribed to achieve a target spKt/V, where V is the volume of distribution of urea. Waste solute production may however be more closely correlated with body surface area (BSA) than V which rises in proportion with body weight. Plasma levels of waste solutes may thus be higher in smaller patients when targeting spKt/V since they have higher BSA relative to body weight. This study measured levels of pseudouridine (PU), a novel marker solute whose production is closely proportional to BSA, to test whether prescription of dialysis to a target spKt/V results in higher plasma levels of PU in smaller children.

METHODS

PU and urea nitrogen (ureaN) were measured in plasma and dialysate at the midweek hemodialysis session in 20 pediatric patients, with BSA ranging from 0.65-1.87m. Mathematical modeling was employed to estimate solute production rates and average plasma solute levels.

RESULTS

The dialytic clearance (K) of PU was proportional to that of ureaN (average K/K 0.69 ± 0.13, r 0.84, p < 0.001). Production of PU rose in proportion with BSA (r 0.57, p < 0.001). The pretreatment plasma level of PU was significantly higher in smaller children (r 0.20, p = 0.051) while the pretreatment level of ureaN did not vary with size.

CONCLUSIONS

Prescribing dialysis based on urea kinetics may leave uremic solutes at higher levels in small children. Measurement of a solute produced proportional to BSA may provide a better index of dialysis adequacy than measurement of urea.

摘要

背景

在儿童和成人中都规定了透析,以达到目标 spKt/V,其中 V 是尿素分布容积。然而,废物溶质的产生可能与身体表面积 (BSA) 更密切相关,而 V 则与体重成比例增加。因此,当以 spKt/V 为目标时,较小患者的血浆废物溶质水平可能更高,因为他们的 BSA 相对于体重更高。本研究测量了假尿嘧啶核苷 (PU) 的水平,一种新型标记溶质,其产生与 BSA 成正比,以测试将透析设定为目标 spKt/V 是否会导致较小儿童的血浆中 PU 水平更高。

方法

在 20 名儿科患者的每周三次血液透析治疗的中间周测量血浆和透析液中的 PU 和尿素氮 (ureaN),BSA 范围为 0.65-1.87m。采用数学模型估算溶质产生率和平均血浆溶质水平。

结果

PU 的透析清除率 (K) 与 ureaN 的透析清除率成正比(平均 K/K 0.69±0.13,r 0.84,p<0.001)。PU 的产生与 BSA 成正比(r 0.57,p<0.001)。较小儿童的预处理血浆 PU 水平显著较高(r 0.20,p=0.051),而预处理尿素 N 水平与体型无关。

结论

基于尿素动力学的透析可能会导致较小儿童的尿毒症溶质水平更高。测量与 BSA 成正比产生的溶质可能比测量尿素更能提供更好的透析充分性指标。

相似文献

1
Plasma pseudouridine levels reflect body size in children on hemodialysis.血浆假尿嘧啶核苷水平反映血液透析患儿的体型。
Pediatr Nephrol. 2020 Feb;35(2):305-312. doi: 10.1007/s00467-019-04369-6. Epub 2019 Nov 14.
2
Adequacy of hemodialysis in acute kidney injury: Real-time monitoring of dialysate ultraviolet absorbance vs. blood-based Kt/Vurea.急性肾损伤中血液透析的充分性:透析液紫外线吸光度与基于血液的Kt/Vurea的实时监测
Hemodial Int. 2021 Jan;25(1):43-49. doi: 10.1111/hdi.12879. Epub 2020 Oct 6.
3
Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.血液透析研究中的尿素清除率(Kt/Vurea)及非尿素小分子溶质水平
J Am Soc Nephrol. 2016 Nov;27(11):3469-3478. doi: 10.1681/ASN.2015091035. Epub 2016 Mar 29.
4
Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.作为更频繁血液透析治疗剂量指南的尿素清除量。
Hemodial Int. 2019 Jan;23(1):42-49. doi: 10.1111/hdi.12692. Epub 2018 Sep 25.
5
Measurement of dialyzer clearance, dialysis time, and body size: death risk relationships among patients.透析器清除率、透析时间和体型的测量:患者之间的死亡风险关系
Kidney Int. 2004 Nov;66(5):2077-84. doi: 10.1111/j.1523-1755.2004.00987.x.
6
A simple method for the calculation of dialysis Kt factor as a quantitative measure of removal efficiency of uremic retention solutes: Applicability to high-dialysate vs low-dialysate volume technologies.一种简单的透析 Kt 因子计算方法,作为衡量尿毒症潴留溶质清除效率的定量指标:适用于高透析液量与低透析液量技术。
PLoS One. 2020 May 29;15(5):e0233331. doi: 10.1371/journal.pone.0233331. eCollection 2020.
7
Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.每周两次血液透析患者中,残余肾功能可有效控制溶质的血中浓度。
J Am Soc Nephrol. 2018 Jul;29(7):1992-1999. doi: 10.1681/ASN.2018010081. Epub 2018 May 4.
8
Obstacles to reducing plasma levels of uremic solutes by hemodialysis.通过血液透析降低尿毒症溶质血浆水平的障碍。
Semin Dial. 2017 Sep;30(5):403-408. doi: 10.1111/sdi.12609. Epub 2017 May 30.
9
Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.治疗持续时间和频率对尿毒症溶质动力学、清除率和浓度的影响。
Semin Dial. 2016 Nov;29(6):463-470. doi: 10.1111/sdi.12531. Epub 2016 Aug 31.
10
Correlates of urea kinetic modeling during hemodialysis in patients with acute renal failure.急性肾衰竭患者血液透析期间尿素动力学模型的相关因素
Blood Purif. 2002;20(2):154-60. doi: 10.1159/000047002.

本文引用的文献

1
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.血液透析滤过与血液透析相比,在儿科人群中并不能降低蛋白结合型尿毒症毒素水平。
Nephrol Dial Transplant. 2020 Apr 1;35(4):648-656. doi: 10.1093/ndt/gfz132.
2
A swan song for Kt/V.Kt/V的绝唱。
Semin Dial. 2019 Sep;32(5):424-437. doi: 10.1111/sdi.12811. Epub 2019 Apr 25.
3
Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.尿毒症毒素浓度与儿科血液透析人群的残余肾功能相关。
Toxins (Basel). 2019 Apr 24;11(4):235. doi: 10.3390/toxins11040235.
4
Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.血液透析滤过与常规血液透析对儿童终末期肾病的影响:HDF、心脏和身高研究。
J Am Soc Nephrol. 2019 Apr;30(4):678-691. doi: 10.1681/ASN.2018100990. Epub 2019 Mar 7.
5
Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.血液透析滤过与传统血液透析对儿童生长及心血管结局的影响——血液透析滤过、心脏与身高(3H)研究
BMC Nephrol. 2018 Aug 10;19(1):199. doi: 10.1186/s12882-018-0998-y.
6
Assessment of dialysis adequacy: beyond urea kinetic measurements.透析充分性评估:超越尿素动力学测量。
Pediatr Nephrol. 2019 Jan;34(1):61-69. doi: 10.1007/s00467-018-3914-6. Epub 2018 Mar 26.
7
A plea for more uremic toxin research in children with chronic kidney disease.呼吁对慢性肾脏病儿童进行更多的尿毒症毒素研究。
Pediatr Nephrol. 2018 Jun;33(6):921-924. doi: 10.1007/s00467-018-3920-8. Epub 2018 Mar 2.
8
Intensive Hemodialysis Fails to Reduce Plasma Levels of Uremic Solutes.强化血液透析未能降低尿毒症溶质的血浆水平。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):361-362. doi: 10.2215/CJN.00950118. Epub 2018 Feb 14.
9
Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.稳定血液透析患者透析前尿毒症毒素浓度随时间的自发变异性。
PLoS One. 2017 Oct 10;12(10):e0186010. doi: 10.1371/journal.pone.0186010. eCollection 2017.
10
Chemical Modifications to RNA: A New Layer of Gene Expression Regulation.RNA的化学修饰:基因表达调控的新层面。
ACS Chem Biol. 2017 Feb 17;12(2):316-325. doi: 10.1021/acschembio.6b00960. Epub 2017 Jan 12.